Thursday, December 08, 2011 10:25:40 AM
http://www.businesswire.com/news/home/20111201005366/en/Fibrocell-Science-Present-Oppenheimer-22nd-Annual-Healthcare
Oppenheimer Healthcare Conference 2011
EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the Oppenheimer 22nd Annual Healthcare Conference to be held on December 13-14, 2011 at the Waldorf=Astoria in New York City.
Fibrocell’s presentation is scheduled for Wednesday, December 14, 2011 at 11:25 AM Eastern Time.
The presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.fibrocellscience.com.
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM